See more : Toosla Société Anonyme (ALTOO.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Lihit Lab.,Inc. (7975.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lihit Lab.,Inc., a leading company in the Business Equipment & Supplies industry within the Industrials sector.
- Azrieli Group Ltd (AZRGF) Income Statement Analysis – Financial Results
- Devro plc (DEVOY) Income Statement Analysis – Financial Results
- Friedrich Vorwerk Group SE (FRVWY) Income Statement Analysis – Financial Results
- WinVest Acquisition Corp. (WINVW) Income Statement Analysis – Financial Results
- STMicroelectronics N.V. (SGM.DE) Income Statement Analysis – Financial Results
Lihit Lab.,Inc. (7975.T)
About Lihit Lab.,Inc.
Lihit Lab.,Inc. manufactures and sells office supplies in Japan and internationally. It offers punch files, Z-type, slide bar and bookbinding, clear holder, pocket holder, and other files; clear books; binders; card, postcard, photo album, and passbook holders; clip type files; clear, file, and document cases. The company also offers P.P. and sewing bags; bag-in-bag products, bag hangers, shoulder belts, and accessory pouches; pencil cases; and notebooks, notebook accessories, and twist ring binding tools. In addition, it provides desk and bookend stands, partition boards, magnetic pocket racks, box files, organizing supplies, office supplies, slide cutters, and steel equipment, as wells as optional parts for electric drills and punches. Further, the company offers medical supplies comprising home medical, medical record folder rack and book, card index, and other medical supplies. Additionally, it provides personal products and electronic equipment related products. Furthermore, the company engages in real estate rental business. It also offers its products through online website. Lihit Lab.,Inc. was founded in 1938 and is headquartered in Osaka, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 8.80B | 8.51B | 8.69B | 8.56B | 9.82B |
Cost of Revenue | 6.28B | 6.01B | 5.79B | 5.54B | 6.53B |
Gross Profit | 2.52B | 2.50B | 2.90B | 3.02B | 3.28B |
Gross Profit Ratio | 28.66% | 29.41% | 33.39% | 35.30% | 33.46% |
Research & Development | 73.00M | 57.00M | 51.00M | 59.00M | 77.65M |
General & Administrative | 411.58M | 396.22M | 397.50M | 400.32M | 138.00M |
Selling & Marketing | 162.79M | 153.18M | 127.72M | 118.51M | 658.00M |
SG&A | 2.63B | 549.40M | 525.22M | 518.83M | 2.72B |
Other Expenses | 102.22M | 2.07M | 3.36M | 401.00K | 0.00 |
Operating Expenses | 2.80B | 2.66B | 2.56B | 2.52B | 2.79B |
Cost & Expenses | 9.08B | 8.67B | 8.35B | 8.06B | 9.32B |
Interest Income | 70.00K | 58.00K | 59.00K | 60.00K | 13.00M |
Interest Expense | 4.72M | 3.39M | 4.97M | 7.80M | 7.88M |
Depreciation & Amortization | 289.14M | 290.19M | 313.62M | 330.36M | 351.02M |
EBITDA | 174.54M | 261.38M | 725.53M | 840.89M | 843.33M |
EBITDA Ratio | 1.98% | 2.96% | 8.21% | 9.69% | 8.59% |
Operating Income | -278.66M | -153.02M | 344.99M | 499.75M | 491.73M |
Operating Income Ratio | -3.17% | -1.80% | 3.97% | 5.84% | 5.01% |
Total Other Income/Expenses | 159.35M | 120.81M | 61.95M | 2.97M | -7.29M |
Income Before Tax | -119.31M | -32.21M | 406.94M | 502.72M | 484.43M |
Income Before Tax Ratio | -1.36% | -0.38% | 4.68% | 5.87% | 4.94% |
Income Tax Expense | -25.58M | -7.80M | 144.43M | 149.78M | 147.04M |
Net Income | -93.73M | -24.41M | 262.51M | 352.95M | 337.39M |
Net Income Ratio | -1.06% | -0.29% | 3.02% | 4.12% | 3.44% |
EPS | -27.62 | -7.19 | 77.36 | 104.00 | 99.47 |
EPS Diluted | -27.62 | -7.19 | 77.36 | 104.00 | 99.47 |
Weighted Avg Shares Out | 3.39M | 3.39M | 3.39M | 3.39M | 3.39M |
Weighted Avg Shares Out (Dil) | 3.39M | 3.39M | 3.39M | 3.39M | 3.39M |
Source: https://incomestatements.info
Category: Stock Reports